AUTONOMIX MEDICAL, INC. Increase (Decrease) in Accrued Liabilities
AUTONOMIX MEDICAL, INC. (AMIX) reported Increase (Decrease) in Accrued Liabilities of -$565.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-13
- AUTONOMIX MEDICAL, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was -$565.00K, a 578.81% decline year-over-year.
- AUTONOMIX MEDICAL, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was $68.00K, a 90.88% decline year-over-year.
- AUTONOMIX MEDICAL, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $291.00K, a 46.23% increase year-over-year.
- AUTONOMIX MEDICAL, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was -$504.00K, a 343.48% decline year-over-year.
- AUTONOMIX MEDICAL, INC. increase (decrease) in accrued liabilities for fiscal 2026 was -$27.00K, a 103.62% decline from fiscal 2025.
- AUTONOMIX MEDICAL, INC. increase (decrease) in accrued liabilities for fiscal 2025 was $746.00K, a 214.77% increase from fiscal 2024.
- AUTONOMIX MEDICAL, INC. increase (decrease) in accrued liabilities for fiscal 2024 was $237.00K, a 415.22% increase from fiscal 2023.
- AUTONOMIX MEDICAL, INC. increase (decrease) in accrued liabilities for fiscal 2023 was $46.00K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$565.00K 10-Q · filed 2026-08-13 | -$497.00K derived: sum of 2 quarters · filed 2026-08-13 | -$206.00K derived: sum of 3 quarters · filed 2026-08-13 | -$710.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $68.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-27 | $359.00K derived: sum of 2 quarters · filed 2026-05-27 | -$145.00K derived: sum of 3 quarters · filed 2026-05-27 | -$27.00K 10-K · filed 2026-05-27 |
| 2025-12-31 | $291.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-11 | -$213.00K derived: sum of 2 quarters · filed 2026-02-11 | -$95.00K 10-Q · filed 2026-02-11 | $651.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-09-30 | -$504.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-12 | -$386.00K 10-Q · filed 2025-11-12 | $360.00K derived: sum of 3 quarters · filed 2026-08-13 | $559.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $118.00K 10-Q · filed 2026-08-13 | $864.00K derived: sum of 2 quarters · filed 2026-08-13 | $1.06M derived: sum of 3 quarters · filed 2026-08-13 | $1.27M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $746.00K 10-K · filed 2025-05-29 | $945.00K derived: sum of 2 quarters · filed 2026-02-11 | $1.15M derived: sum of 3 quarters · filed 2026-02-11 | $746.00K 10-K · filed 2026-05-27 |
| 2024-12-31 | $199.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-11 | $406.00K derived: sum of 2 quarters · filed 2026-02-11 | $597.00K 10-Q · filed 2026-02-11 | $834.00K derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-09-30 | $207.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-12 | $398.00K 10-Q · filed 2025-11-12 | $635.00K derived: sum of 3 quarters · filed 2025-11-12 | $911.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $191.00K 10-Q · filed 2025-08-13 | $428.00K derived: sum of 2 quarters · filed 2025-08-13 | $704.00K derived: sum of 3 quarters · filed 2025-08-13 | $670.00K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $237.00K 10-K · filed 2025-05-29 | $513.00K derived: sum of 2 quarters · filed 2025-05-29 | $479.00K derived: sum of 3 quarters · filed 2025-05-29 | $237.00K 10-K · filed 2024-05-31 |
| 2023-12-31 | $276.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-13 | $242.00K derived: sum of 2 quarters · filed 2025-02-13 | $262.00K 10-Q · filed 2025-02-13 | $310.00K derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-09-30 | -$34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-08 | -$14.00K 10-Q · filed 2024-11-08 | $34.00K derived: sum of 3 quarters · filed 2024-11-08 | |
| 2023-06-30 | $20.00K 10-Q · filed 2024-08-13 | $68.00K derived: sum of 2 quarters · filed 2024-08-13 | ||
| 2023-03-31 | $48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-31 | $46.00K 10-K · filed 2024-05-31 | ||
| 2022-12-31 | -$2.00K 10-Q · filed 2024-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |